Patent Assignment
Reel/Frame 065451/0415
Assignment of Assignor's Interest
Recorded: 2023-11-03
Pages: 8
Assignor
VENTUS THERAPEUTICS, INC.
Executed: 2023-09-13
Assignees
NOVO NORDISK A/S
NOVO ALLE, BAGSVAERD, DK-2880, DENMARK
VENTUS THERAPEUTICS U.S., INC.
100 BEAVER STREET, SUITE 201, WALTHAM, MASSACHUSETTS, 02453
Covered Property
(1)
Compounds for Inhibiting NLRP3 and Uses Thereof
Patent:
11,319,319 →
Application:
17/528,928 →
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 31, 2022
From: DORICH, STEPHANE; BURCH, JASON; ST-ONGE, MIGUEL; CHEFSON, AMANDINE
To: VENTUS THERAPEUTICS U.S., INC.
Reel/Frame 060058/0286 →
Assignment of Assignor's Interest
Nov 3, 2023
From: DORICH, STÉPHANE; CHEFSON, AMANDINE; CÔTÉ, ALEXANDRE
To: VENTUS THERAPEUTICS, INC.
Reel/Frame 065451/0385 →
Corrective Assignment to Correct the Receiving Party's Data by Removing Novo Nordisk a/S as Assignee. Previously Recorded on Reel 065451 Frame 0415. Assignor(S) Hereby Confirms the Assignment.
Nov 7, 2023
From: VENTUS THERAPEUTICS, INC.
To: VENTUS THERAPEUTICS U.S., INC.
Reel/Frame 065594/0619 →